BEAM

#1368
Beam Therapeutics Inc. - Common Stock
32.9 3 USD
-0.12%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
32.93
32.93
Year Range
15.35
36.44
Daily Change
-0.12%
Monthly Change
+11.59%
6 month change
+32.89%
Year Change
+103.90%
Previous Close
32.9 7
Open
32.9 3
Low
32.9 3
High
32.9 3
Volume
211
Open full chart Full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Income statement Balance sheet Cash flow
Value Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM

Beam Therapeutics Inc. - Common Stock

Beam Therapeutics Inc. is an American biotechnology company conducting research in the field of gene therapies and genome editing. The company is headquartered in Cambridge, Massachusetts. In the development of therapies, the company relies on CRISPR base editing and prime editing, whereby single nucleotides in a DNA sequence can be enzymatically modified without producing double-strand breaks.

News